Preparation of BST2 Targeted Ultrasound Contrast Agent and Its in Vitro Binding with Tumor Cells

CHEN Juan-juan,YAN Fei,JIN Qiao-feng,LI Lu,ZHENG Hai-rong,LIU Xian-jun

DOI: https://doi.org/10.13929/j.1003-3289.2012.05.036

2012-01-01

Abstract:Objective To investigate the feasibility of bone marrow stromal antigen 2(BST2) as a potential target for prostate cancer by preparation of BST2 targeted microbubbles as ultrasound contrast agent and evaluation on the in vitro targeting ability with mouse prostate tumor cells(RM-1) and breast cancer cells(4T1).Methods By immunofluorescence staining and Western blotting assays,the expression level of BST2 protein was analyzed and compared in both RM-1 and 4T1 cells.The biotinylated anti-BST2 monoclonal antibody was used to prepare targeted microbubbles through the biotin-avidin bridge.The resulting BST2-targeted microbubbles were observed under light microscope and characterized by AccuSizer 780A particle size analyzer.The targeting specificity and attachment capability of the BST2 targeted microbubbles to RM-1 and 4T1 cells were assessed in vitro.Results Expression of BST2 protein in RM-1 cells was significantly higher than in 4T1 cells.BST2 targeted microbubbles attached with tumor cells obviously compared with non-targeted microbubbles.RM-1 cells possessed significantly higher attachment capability than that with 4T1 cells in vitro.Conclusion BST2 targeted microbubbles are successful prepared,which are able to specifically adhere to RM-1 cells,therefore serving as a potential valuable targeted probe for ultrasound molecular imaging of prostate cancer.